FDA Adverse Event Death Summary report: N

IMPELLA

MDR report key: 24924272 · Received April 20, 2026

Report

Report Number
1220648-2026-06950
Event Type
Death
Date Received
April 20, 2026
Date of Event
April 15, 2026
Manufacturer
ABIOMED, INC. - 1220648
Product Code
OZD
UDI-DI
00813502012279
PMA / PMN Number
P140003
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY ABIOMED INC, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, ABIOMED INC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 0

CORRECTED INFORMATION WAS PROVIDED IN D3 (MANUFACTURER FAX). UPON REVIEW, IT WAS IDENTIFIED THAT IT WAS INADVERTENTLY OMITTED FROM THE INITIAL REPORT. CORRECTED INFORMATION WAS PROVIDED IN D4 (SERIAL NUMBER). UPON REVIEW, THE SECTION D SERIAL NUMBER HAS NOW BEEN UPDATED. CORRECTED INFORMATION WAS PROVIDED IN E3 (INITIAL REPORTER OCCUPATION). UPON REVIEW, IT WAS IDENTIFIED THAT IT WAS INADVERTENTLY SUBMITTED IN ERROR IN THE INITIAL REPORT. H6: UPDATED CODES BASED ON THE RESULTS OF THE INVESTIGATION. H11: UPDATED BASED ON THE RESULTS OF THE INVESTIGATION. THE ROOT CAUSE OF THE INJURY WAS UNABLE TO BE DETERMINED DUE TO INSUFFICIENT CLINICAL DETAILS.

Description of Event or Problem · 0

CLINICAL NARRATIVE: AN IMPELLA CP WAS INSERTED VIA THE FEMORAL ARTERY TO SUPPORT THE 75 YEAR OLD FEMALE PATIENT WHO HAD BEEN ADMITTED IN WITH ACUTE MYOCARDIAL INFARCTION AND CARDIOGENIC SHOCK, PRESENTING IN SCAI STAGE D SHOCK. THE PATIENT WAS ON INOTROPES, VASOPRESSORS, AND A VENT FOR RESPIRATORY NEEDS. THE PATIENT'S UNDERLYING MEDICAL HISTORY WAS NOT SHARED. THE PUMP WAS PLACED VIA THE FEMORAL AND ON THE DAY AFTER IMPLANT THE PULSE COULD NOT LONGER BE FOUND ON THE IMPELLA ACCESSED LEG. THE LEG COLOR HAD ALSO CHANGED. THE TEAM WAS AWARE THAT THE VASOPRESSORS HAD BEEN ELEVATED THE NIGHT BEFORE. THE PLAN WAS TO BRING THE PATIENT FOR A FEM-FEM BYPASS BUT, THE PATIENT EXPIRED BEFORE THE INTERVENTION COULD BE ACCOMPLISHED. THE PUMP HAD SUPPORTED FOR ONLY 21 HOURS BEFORE THE PATIENT EXPIRED. THE CAUSE OF DEATH WAS NOT SHARED. ISCHEMIA MAY BE INFLUENCED BY PATIENT-SPECIFIC FACTORS SUCH AS SEVERE PERIPHERAL VASCULAR DISEASE, UNDERLYING CRITICAL ILLNESS, HEMODYNAMIC INSTABILITY, AND VASCULAR ACCESS CHARACTERISTICS. THE DEATH IS CONSERVATIVELY BEING REPORTED ALTHOUGH AN UNLIKELY CONTRIBUTING FACTOR TO THE DEATH, AND MORE LIKELY THE PATIENT'S PRESENTING NATIVE CRITICAL CONDITION AS PRESENTED IN SCAI STAGE D.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
586268 IMPELLA TEMPORARY NON-ROLLER TYPE LEFT HEART SUPPORT BLOOD PUMP OZD ABIOMED, INC. - 1220648 2027860699 00813502012279

Patients

Seq Age Sex Outcome Treatment
1 75 YR Female Required Intervention| D